Here are four things to know:
1. During the forecast period, the market is expected to grow at a 24.1 percent compound annual growth rate.
2. In 2017, the market was worth a little more than $375 million.
3. The report attributes a rising number of musculoskeletal diseases, an increase in funds allocated for medical robot research and technology advancements in orthopedic surgery assisted robots as factors contributing to the market’s growth.
4. The high cost of medical robotic systems and safety concerns may act as restraining market factors, according to the report.
More articles on devices:
3 things to know about Nexxt Spine
Zirconium may outpace titanium as most common implantable medical device material: 3 insights
Neurosurgeon joins Assure’s board of directors: 5 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
